Amphastar Pharmaceuticals, Inc.
AMPH
$19.20
-$0.34-1.74%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.65% | -57.09% | -18.23% | -41.44% | 4.97% |
| Total Depreciation and Amortization | 9.02% | 9.25% | 14.80% | 8.91% | 6.35% |
| Total Amortization of Deferred Charges | 19.61% | 18.95% | -65.44% | -64.19% | -75.15% |
| Total Other Non-Cash Items | 318.01% | -43.65% | 1.04% | 220.47% | -596.37% |
| Change in Net Operating Assets | -397.43% | 263.74% | -314.53% | -130.06% | 67.88% |
| Cash from Operations | 13.23% | -12.31% | -48.50% | -36.56% | 21.62% |
| Capital Expenditure | 33.35% | 61.23% | -74.80% | -21.65% | -31.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.77% | 31.37% | -84.74% | -11.87% | 75.14% |
| Cash from Investing | -69.77% | 43.27% | 99.11% | -31.21% | 65.38% |
| Total Debt Issued | -94.39% | -98.19% | 16,616.00% | -59.77% | -- |
| Total Debt Repaid | 9.57% | -7.32% | 99.54% | 61.22% | 99.77% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 46.87% | 84.70% | -1,187.18% | 9.39% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -136.36% | 99.32% | -25,400.00% | -67.46% | 104.48% |
| Cash from Financing | 45.71% | 80.95% | -181.84% | -6.80% | 28.12% |
| Foreign Exchange rate Adjustments | 18.18% | 34.92% | 847.37% | 221.65% | 95.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.78% | 1,044.41% | 142.56% | -45.17% | 67.98% |